Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neovastat in Refractory and Early Relapse Multiple Myeloma
NCT00022282Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Apr 2001
- Primary completion
- Mar 2007
- Modality
- Biologic, Angiogenesis inhibitor, Metalloprotease inhibitor
- Countries
- 1
01
Overview
A Phase 2 trial of Neovastat in multiple myeloma (MM), sponsored by COSCIENS Biopharma Inc.. Started Apr 2001; status: completed.
02
Drugs
Neovastat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00022282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022282.